18 studies found for:
" March 20, 2007":" April 19, 2007"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Active, not recruiting |
PET Evaluation of Brain Peripheral Benzodiazepine Receptors Using [11C]PBR28 in HIV-Seropositive Patients With (MCMD)
|
||||
| 2 |
Completed
Has Results |
Treatment Simplification by Darunavir/Ritonavir 800/100 mg Once a Day Versus a Triple Combination Therapy With Darunavir/Ritonavir
|
||||
| 3 | Completed |
Prospective Epidemiological Study Of The Prevalence Of HLA-B*5701
|
||||
| 4 |
Completed
Has Results |
HIV-1 Infection Study of Once a Day Versus Twice a Day Protease Inhibitor in Antiretroviral Treatment Naive Adults
|
||||
| 5 | Recruiting |
Therapeutic Approaches to HAART-Induced Lipodystrophy
|
||||
| 6 | Completed |
Isoniazid Plus Antiretroviral Therapy to Prevent Tuberculosis in HIV-infected Persons
|
||||
| 7 | Recruiting |
Emtricitabine/Tenofovir Disoproxil Fumarate for HIV Prevention in Men
|
||||
| 8 | Completed |
Clinical Trial to Assess the Efficacy of Darunavir/Ritonavir (DRV/r), Etravirine (ETV) and Raltegravir (MK-0518) in HIV Patients With Resistant Viruses
|
||||
| 9 | Completed |
Mechanisms of Lipodystrophy in HIV-Infected Pateints
|
||||
| 10 | Completed |
Comparison of Plasma Drug Levels of Triomune 40 With Those of the Originator Products
|
||||
| 11 | Recruiting |
Subclinical Atherosclerosis in HIV-infected Patients
|
||||
| 12 | Completed |
Efficacy and Tolerance of the Switch From Enfuvirtine to Raltegravir in Antiretroviral Therapy Regimen in HIV Patients With Undetectable Viral Load
|
||||
| 13 |
Completed
Has Results |
Treatment of Oral Warts in HIV+ Patients
|
||||
| 14 | Completed |
Safety of and Immune Response to a Meningitis Vaccine in HIV-Infected Children and Youth
|
||||
| 15 | Completed |
CMV Disease and IRIS in HIV-1 Infected Persons
|
||||
| 16 | Terminated |
ESP Study: A Study to Assess the Effect of Adding Fuzeon (Enfuvirtide) to an Antiretroviral Regimen in Fuzeon-Naive Patients With Sustained HIV Viral Suppression.
|
||||
| 17 | Unknown † |
Hepatitis Vaccination in HIV Infection: Role of Adjuvant Interleukin-2
|
||||
| 18 |
Completed
Has Results |
Enfuvirtide/Current Protease Inhibitor Switch to PREZISTA (Darunavir)/Ritonavir + TMC125 in HIV Patients With Enfuvirtide Side Effects.
|
† Indicates status has not been verified in more than two years